Almac Overview.

Transcription

1 Almac Overview

2 2 Welcome to Almac

3 3 Who is Almac? Almac is a world leading drug development & commercial services company; providing an expanding array of innovative solutions worldwide across the drug development lifecycle

4 4 Our Vision Statement Almac will be the leader in the generation of superior solutions for the advancement of human health

5 5 Almac: An Integrated Group

6 6 Milestones

7 7 Background Founded in 1968 Global Headquarters in Craigavon, Northern Ireland Turnover $0.5 billion+ (CMO market est. approx. $14bn) ~ 4,000+ Personnel Globally Unique ownership- charitable foundation: McClay Foundation All Profit Re-invested

8 8 Our Global Presence DEPOTS ON 60 6 CONTINENTS SHIPMENTS ANNUALLY To over 80 countries Facilities with 4,000+ personnel in: Europe : Northern Ireland, Republic of Ireland, Scotland, England US: Pennsylvania, North Carolina, California Asia: Japan, Singapore TO OVER 80 COUNTRIES

9 9 Diverse Customer Base 1% 4% 2% Pharma - Large Pharma - Medium Pharma - Small Biotech CRO Academia Other Speciality Diagnostics 6% 29% 5% 10% 10% 33% Diverse client base across the Group assuring stability

10 10 Overview of Almac s market position Almac Group A unique range of services and solutions and a wide range of competitors (depending on which area of the business you look at) Clinical Services Clinical Technologies Pharma Services Sciences Diagnostics Top 3 service provider for clinical supply services globally Industry leader top 5 globally Smaller player, well known for solid oral dose capabilities Smaller player, broad range of service offerings supported by excellent science Smaller player, more niche offering + Galen (branded pharmaceuticals) and (R&D)

11 11 Pipeline Delivery R & D Process / Scale Up Formulation Clinical Trials Manufacturing & Packaging Sales & Marketing The Almac Group provides all of the services required to take a new drug or compound from concept right through to final patient delivery. World Class Pharmaceutical Solutions

12 12 Services/Solutions CLINICAL SERVICES CLINICAL TECHNOLOGIES PHARMA SERVICES SCIENCES DIAGNOSTICS & BIOMARKERS Clinical Packaging Distribution Storage Blinding Commercial drug procurement Supply chain management Interactive response technology (IRT) Electronic patient reported outcomes Bio statistical services Pharmaceutical development Commercial manufacturing Commercial Packaging Product launch, distribution and other commercial services API services Chemical development Analytical services Solid state services Biocatalysis Peptides Internal diagnostic development Biomarker discovery Companion diagnostics development

13 13 Delivery R & D Process / Scale Up Formulation Clinical Trials Manufacturing & Packaging Sales & Marketing

14 14 A project generator for highly novel oncology programmes for the pharmaceutical companies. It operates in the discovery to preclinical space and provides Phase I ready programmes. Exceptionally, it may chose to take a programme into Phase I Clinical Trials

15 16 Delivery R & D Process / Scale Up Formulation Clinical Trials Manufacturing & Packaging Sales & Marketing

16 17 Diagnostics Microarray based Cancer Diagnostics Company Develops, markets and supplies: Leading edge genomic expression services Products that will radically improve the diagnosis and treatment of cancer

17 18 Delivery R & D Process / Scale Up Formulation Clinical Trials Manufacturing & Packaging Sales & Marketing

18 19 Sciences API Supply Synthesis design Peptide API Drug Product Clinical manufacture Scale up Analytical Services Stability Release and comparator testing Method development

19 20 Delivery R & D Process / Scale Up Formulation Clinical Trials Manufacturing & Packaging Sales & Marketing

20 21 Clinical Services Clinical Supplies management company Covers complete supply chain for Clinical Trials: blinding packaging global distribution consulting/project management

21 22 Delivery R & D Process / Scale Up Formulation Clinical Trials Manufacturing & Packaging Sales & Marketing

22 Clinical Technologies Managed clinical studies to date Supported nearly 2 million patients Worked with 18/20 top biopharma companies Renowned biostats staff Global trials conducted across 85 countries Conducted trials in 60 languages

23 Interactive Response Technology - IXRS Patient Randomization & Blind Protection Product Inventory Management Patient Tracking & Status Study Management Data Availability

24 26 Delivery R & D Process / Scale Up Formulation Clinical Trials Manufacturing & Packaging Sales & Marketing

25 27 Pharma Services Formulation - from API to tablet Commercial Manufacture & Packaging Distribution & Logistics - global distribution - inventory management (TROPOS) - 3PL & POP - late stage customisation

26 28 Delivery R & D Process / Scale Up Formulation Clinical Trials Manufacturing & Packaging Sales & Marketing

27 29 Galen Galen promotes branded and generic prescription medicines in the UK & Ireland e.g. Calceos (for osteoporosis) Laxido Orange (for chronic constipation) Flotros (for overactive bladder) Penthrox (Analgesic) Launched Jan 2016 Trustsaver Portfolio

28 30 Commercialisation Galen Galen Ltd Recognised Speciality Pharmaceutical Company Products Sold into 23 Countries Successful Entrance into US Market in 2012 Therapy Areas include: Oncology Gastroenterology Female Health Pain Management

29 31 The Future We are a global player and we will continue to increase our presence throughout the world. We will continue to develop new technologies, new medical interventions and new markets. We will achieve our vision.